Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
International Flavors & Fragrances Inc. has reached an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners for approximately $4.3 billion. The transaction, which values the unit at an enterprise value-to-EBITDA multiple of roughly 10x, leaves IFF with a 10% minority equity stake and a board seat in the new compa…
Brazil's economy returned to expansion in the first quarter, registering 1.1% growth from the previous quarter. The uptick was led by household spending and a rise in gross fixed capital formation, with agriculture and the extractive industry contributing on the supply side. Annual GDP rose 1.8%, in line with market forecasts.
SkyAI, a Nasdaq-listed fintech company focused on agentic finance for the Global South, has appointed Arthur Levine as Chief Financial Officer. Levine brings over 30 years of expertise in public company finance, having successfully led IPOs and growth initiatives. His addition is expected to bolster SkyAI's financial operations and infrastructure t…
Lianhe Sowell International Group Ltd., a Nasdaq-listed provider of industrial machine vision and robotics solutions, announced the approval of five key proposals at its extraordinary general meeting held on May 29, 2026. These include a 16-for-1 share consolidation, a significant increase in authorized share capital from $50,000 to $80 million, am…
Palomar Holdings, Inc. announced the successful completion of its June 1, 2026 reinsurance placement, boosting its earthquake and hurricane event coverage limits significantly. The company secured $421 million in additional limits, expanded its catastrophe bond issuance, and maintained prudent retention levels, resulting in an increased full-year 2…
Optimi Health Corp. acknowledged Australia's Therapeutic Goods Administration updated Authorized Prescriber framework, broadening therapist eligibility and treatment settings for psychedelic-assisted therapies using Optimi's MDMA and psilocybin products. These changes support scalable commercial growth as Australia leads globally in prescribed psyc…
Krispy Kreme Inc. (DNUT) stock climbed in premarket trading after director Bernardo Hees disclosed purchases of 225,077 shares through BHBK LLC between May 26 and May 28. The transactions increased the director's indirect holdings via the LLC to 919,522 shares and left him with 702,728 shares held directly, including unvested restricted stock units…
The Chief Financial Officer of Unusual Machines, Inc., Brian Hoff, recently sold a significant block of company shares. This activity occurred against the backdrop of mixed quarterly financial results for the firm, which reported an earnings miss but strong year-over-year revenue growth. Furthermore, recent reports regarding potential Pentagon fund…
Italian prosecutors have launched an investigation into the Italian branch of Alabama-based Caddell Construction, alleging that a large number of Indian workers employed at the U.S. consulate construction site in Milan were recruited through an intermediary in New Delhi and subjected to exhausting shifts, low pay, inadequate safety protections and …
Tempus AI, Inc. (NASDAQ:TEM) saw its shares rise 3.5% on Friday after receiving FDA approval to run its xT CDx next-generation sequencing platform as a tumor-only assay. The decision makes Tempus the first laboratory with FDA companion diagnostic clearances covering both tumor-only and tumor-normal comprehensive genomic profiling. The approval is e…
Moleculin Biotech announced new data at ASCO 2026 demonstrating that Annamycin, their lead drug candidate, shows no detectable cardiotoxicity even at cumulative doses far exceeding conventional anthracycline limits. An independent review by Cleveland Clinic specialists supports a differentiated cardiac safety profile. The data bolster ongoing pivot…
Wolfe Research downgraded Boston Scientific to Peer Perform, signaling an end to a multiyear bullish thesis after two primary growth catalysts - pulsed field ablation (PFA) and the Watchman left atrial appendage closure device - faltered sharply in the first half of 2026. Analyst Mike Polark, who had supported the stock for four years, lowered his …
Preliminary national statistics show German headline inflation eased to 2.7% in May from 2.9% the prior month, while core inflation - excluding food and energy - climbed to 2.5% from 2.3%. The data precedes an expected uptick in euro zone inflation and increases the chance of monetary policy action by the European Central Bank.
Science Applications International Corp. (SAIC) announced a cash dividend of $0.37 per share payable on July 24, 2026, to shareholders of record as of July 10, 2026. SAIC intends to continue quarterly dividend payments, subject to board approval each quarter, based on earnings and financial condition. The company is a leading mission integrator spe…
uniQure stock jumped about 20% on Friday following news that Replimune has reached alignment with the U.S. Food and Drug Administration to resubmit a Biologics License Application for RP1 in combination with nivolumab for advanced melanoma. Replimune's shares rose roughly 70% after announcing imminent BLA resubmission, reversing a prior agency reje…
Judith A. Hannaway, a director at FTAI Aviation Ltd., executed both a sale and an acquisition of company shares in May 2026. This activity occurred amidst several major corporate developments for FTAI Aviation, including reporting strong Q1 revenue beats, but also missing earnings per share forecasts. Furthermore, the company received a rating upgr…
Rail Vision Ltd., a Nasdaq-listed company specializing in AI-integrated railway safety systems, has signed a non-binding MOU with Railserve Inc., a Marmon Rail company, to expand collaboration beyond a prior commercialization agreement. The partnership focuses on deploying Rail Vision's AI-based ShuntingYard systems to enhance rail yard operations,…
U.S. stock futures were modestly higher Friday morning following reports that the U.S. and Iran agreed to extend a ceasefire and remove restrictions on vessels transiting the Strait of Hormuz. In premarket trading, Dell jumped after raising its full-year outlook, while peers and other corporate developments produced a range of outsized moves across…
Ally Financial (ALLY) is trading at a discount to book and earnings despite solid fundamentals: $13.1B market cap, trailing P/E ~10x, P/B ~0.84 and $1.1B in free cash flow. Macro headwinds in auto demand and tighter credit could pressure results near term, but the combination of yield-sensitive NIM expansion and a durable digital deposit franchise …
SAB Biotherapeutics announced that it will present clinical data on SAB-142, its lead immunotherapy candidate for newly diagnosed Stage 3 type 1 diabetes, at the American Diabetes Association's 2026 Scientific Sessions and the Federation of Clinical Immunology Societies 2026 Annual Meeting. The presentations will showcase SAB-142's safety, pharmaco…
LGI Homes, Inc. has announced the grand opening of Trails West, a new 529-home master-planned community in West Jacksonville, Florida. The community offers upgraded homes starting in the $240,000s, a variety of floor plans, and planned amenities aimed at families seeking affordability and quality in a fast-growing region. This development complemen…
PetMed Express, Inc., a leading online pet pharmacy, announced it will release its financial results for the fourth quarter and fiscal year ended March 31, 2026, on June 2, 2026 after market close. The company will also host a live conference call and webcast the same day to discuss these results.
Rhythm Pharmaceuticals announced that seven abstracts, including four late-breaking presentations, have been accepted for the Endocrine Society's Annual Meeting (ENDO 2026). These presentations will share new clinical data on setmelanotide and bivamelagon in treating rare neuroendocrine disorders such as Prader-Willi syndrome, acquired hypothalamic…
Tenaya Therapeutics, a clinical-stage biotech focused on gene therapies for heart disease, announced its participation in the Jefferies Global Healthcare Conference with CEO Faraz Ali presenting on June 4, 2026. The company highlighted its pipeline including gene therapies targeting hypertrophic cardiomyopathy and arrhythmogenic right ventricular c…
Tempest Therapeutics, a clinical-stage biotech company specializing in CAR-T cell therapies for cancer, announced the exercise of outstanding warrants at a reduced price, generating gross proceeds of about $2 million. The company also issued new unregistered short-term warrants with a potential to raise an additional $4 million if fully exercised, …
